CIVALLERO, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.666
AS - Asia 1.609
EU - Europa 1.437
SA - Sud America 251
AF - Africa 58
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.028
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.620
SG - Singapore 494
CN - Cina 441
GB - Regno Unito 434
IT - Italia 268
VN - Vietnam 205
HK - Hong Kong 200
BR - Brasile 178
SE - Svezia 154
DE - Germania 130
RU - Federazione Russa 86
FI - Finlandia 82
UA - Ucraina 65
FR - Francia 63
TR - Turchia 51
KR - Corea 36
IN - India 32
IE - Irlanda 28
ID - Indonesia 27
BG - Bulgaria 24
AR - Argentina 22
CA - Canada 22
JP - Giappone 19
MA - Marocco 19
BE - Belgio 18
NL - Olanda 18
BD - Bangladesh 17
IQ - Iraq 16
MX - Messico 16
ZA - Sudafrica 16
EC - Ecuador 13
CL - Cile 10
MY - Malesia 9
AT - Austria 8
PE - Perù 8
EG - Egitto 7
LB - Libano 7
LT - Lituania 7
PK - Pakistan 7
PL - Polonia 7
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
ES - Italia 6
JO - Giordania 5
ET - Etiopia 4
PH - Filippine 4
PT - Portogallo 4
UY - Uruguay 4
AU - Australia 3
BO - Bolivia 3
CO - Colombia 3
IR - Iran 3
KE - Kenya 3
PY - Paraguay 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
KZ - Kazakistan 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
PR - Porto Rico 2
QA - Qatar 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AM - Armenia 1
BF - Burkina Faso 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 7.024
Salva come PNG Salva come JPEG
Città #
Ashburn 478
Fairfield 375
Santa Clara 342
Singapore 325
Southend 304
Chandler 259
Woodbridge 236
Hong Kong 197
Houston 161
San Jose 142
Ann Arbor 130
Seattle 121
Cambridge 117
Nyköping 109
Wilmington 104
Beijing 83
Jacksonville 83
Hefei 82
London 80
Dearborn 78
Helsinki 61
Modena 59
Ho Chi Minh City 58
The Dalles 57
Hanoi 54
Council Bluffs 52
New York 50
Los Angeles 46
San Diego 40
Chicago 37
Seoul 36
Frankfurt am Main 31
Dublin 28
Izmir 27
Princeton 25
Moscow 24
Sofia 24
Fremont 22
Jakarta 22
Lauterbourg 22
Munich 22
Dallas 21
Shanghai 21
Eugene 19
São Paulo 19
Brussels 18
Milan 18
Salt Lake City 17
Casablanca 16
Cologno Monzese 16
Norwalk 12
Tokyo 12
Buffalo 10
Des Moines 10
Pisa 10
Johannesburg 9
Montreal 9
Orem 9
San Giuliano Milanese 9
Bremen 8
Columbus 8
Falls Church 8
Lviv 8
Amsterdam 7
Atlanta 7
Brusaporto 7
Chongqing 7
Da Nang 7
Haiphong 7
Nuremberg 7
Parma 7
Redondo Beach 7
Boardman 6
Boston 6
Changsha 6
Dong Ket 6
Guangzhou 6
Phoenix 6
Redwood City 6
Rome 6
San Francisco 6
Baghdad 5
Bologna 5
Brasília 5
Brooklyn 5
Campinas 5
Caracas 5
Contagem 5
Kuala Lumpur 5
Lappeenranta 5
Latina 5
Lima 5
Ottawa 5
Quito 5
Rio de Janeiro 5
Tampa 5
Thái Nguyên 5
Warsaw 5
Addis Ababa 4
Amman 4
Totale 5.100
Salva come PNG Salva come JPEG
Nome #
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma 380
Activity of BKM120 and BEZ235 against lymphoma cells 362
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 355
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine 345
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 339
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery 327
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma 284
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases 280
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy 279
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells 279
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines 275
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 272
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 271
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 270
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 263
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 249
Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression 241
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination 226
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project 224
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project 214
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project 191
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 183
COVID-related disruption in mammographic screening: a year later. 175
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply 166
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project 147
The Value and relevance of T-cell lymphoma registries 147
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network 143
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project 139
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 51
Totale 7.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 0 0 0 0 0 0 83 51 38
2021/2022555 36 29 63 29 9 64 36 22 44 46 107 70
2022/2023648 74 114 44 66 43 95 7 57 88 7 25 28
2023/2024421 18 24 18 50 82 34 43 47 5 17 48 35
2024/20251.230 50 11 36 103 233 179 96 68 120 43 102 189
2025/20262.144 176 84 165 227 323 188 343 145 274 219 0 0
Totale 7.077